Salivary biomarkers and its implication in tobacco users-A narrative review
Article Sidebar
-
Biomarkers, Tobacco, Oral Health
Abstract
Tobacco has been associated with diverse diseases on the mouth, oral potentially malignant disorders, oral cancer and systemic diseases/cancer. The prevalence of oral cancer is high with tobacco users. The local and systemic physiology is altered by tobacco-related chemicals/metabolites. These may reflect as biomarkers of tobacco use, and they also influence the level of different biomarkers. Saliva being the initial body fluid influenced by the presence of these biomarkers and possess additional advantage to monitor, diagnose or prevent tobacco-associated illness by assessing the same. This narrative review aims to emphasize the different salivary biomarker studies and their inference on tobacco users. Articles have been collected from a different search engine, and the results were assessed to highlight their importance on human health. These markers can be further validated as diagnosing and/or predicting markers in high-risk tobacco users. In addition, the recognized readily available non-invasive salivary markers would be a great source for patient education and promoting health awareness in such groups.
Full text article
References
Ali, S., Amer, E. 2017. Evaluation of the salivary level of mir-21 in cigarette smokers: a case-control study. Egyptian Dental Journal, 63(2):1507–1512. ISSN: 2090-2360.
Ekezie, W., Murray, R. L., Agrawal, S., Bogdanovica, I., Britton, J., Leonardi-Bee, J. 2020. Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review. Clinical Medicine, 20(6):551–559. ISSN: 1470-2118, 1473-4893.
Jayaram, R., Anitha, J. U. 2019. The oral changes due to tobacco consumption: A diagnostic perspective. J Med Biomed App Sci, 7(11):294–299.
Karkera, N. K., Guttal, K. S., Shetty, P. K., Bargale, A. B., Kulkarni, R. D., Kulkarni, B. B. 2017. Effects of salivary e-cadherin(cdh1-160) gene promoter polymorphism on the risk of development of oral cancer in Indian origin. International Journal of Current Research, 9(04):975–833.
Kudielka, B. M., Hellhammer, D. H., Wüst, S. 2009. Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology, 34(1):2–18. ISSN: 0306-4530.
Kurtul, N., Gökpınar, E. 2012. Salivary Lipid Peroxidation and Total Sialic Acid Levels in Smokers and Smokeless Tobacco Users as Maraş Powder. Mediators of Inflammation, 2012:1–8. ISSN: 0962-9351, 1466-1861.
Lewis, S. J., Cherry, N. M., Niven, R. M., Barber, P. V., Wilde, K., Povey, A. C. 2003. Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic. Biomarkers, 8(3-4):218– 228. ISSN: 1354-750X, 1366-5804.
Lira-Junior, R., Åkerman, S., Gustafsson, A., Klinge, B., Boström, E. A. 2017. Colony stimulating factor-1 in saliva in relation to age, smoking, and oral and systemic diseases. Scientific Reports, 7(1):20–20. ISSN: 2045-2322.
Mathur, P., Sathishkumar, K., Chaturvedi, M., Das, P., Sudharshan, K. L., Santhappan, S. 2020. Report from National Cancer Registry Programme India. JCO Global oncology, 6:1063–75.
Mori, M., Sumitomo, S., Shrestha, P., Tanaka, S., Takai, Y., Shikimori, M. 2008. Multifunctional roles of growth factors or biologically active peptides in salivary glands and saliva. Oral Medicine and Pathology, 12(4):115–123. ISSN: 1342-0984, 1882-1537.
Morris, M. C., Mielock, A. S., Rao, U. 2016. Salivary stress biomarkers of recent nicotine use and dependence. The American Journal of Drug and Alcohol Abuse, 42:640–648. ISSN: 0095-2990, 1097-9891.
Naresh, C. K., Raosm, Shettypr, Ranganathv, Patilas, A. 2019. Salivary antioxidant enzymes and lipid peroxidation product malondialdehyde and sialic acid levels among smokers and non-smokers with chronic periodontitis-A clinic-biochemical study. Family Med Prim Care, 8(9):2960–2964.
Nater, U. M., Marca, R. L., Florin, L., Moses, A., Lang- hans, W., Koller, M., Ehlert, U. 2006. Stress-induced changes in human salivary alpha-amylase activity—associations with adrenergic activity. Psychoneuroendocrinology, 31(1):49–58. ISSN: 0306-4530.
Ramzanan, A., Mcculloughmj, Segundo, M. A., Kolevsd 2018. Determination of salivary cotinine as tobacco smoking biomarker. TrAC Trends in Analytical Chemistry, 105:89–97.
Rodriguez-Rabassa, M., Lopez, P., Rodriguez- Santiago, R. E., Casesa, Felici, M., Sanchez, R. 2018. Cigarette smoking modulation of saliva microbial composition and cytokine levels. Int J environ res public health, 15(11):2479.
Schick, S. F., Blount, B. C., Jacob, P., Saliba, N. A., Bernert, J. T., Hellani, A. E., Jatlow, P., Pappas, R. S. 2017. Biomarkers of exposure to new and emerging tobacco delivery products. American Journal of Physiology-Lung Cellular and Molecular Physiology, 313(3):L425–L452. ISSN: 1040-0605, 1522-1504.
Slavish, D. C., Graham-Engeland, J. E., Smyth, J. M., Engeland, C. G. 2015. Salivary markers of inflammation in response to acute stress. Brain, Behavior, and Immunity, 44:253–269.
Sohail, K., Siddiqi, M. K., Baig, M. Z., Sahibzada, H. A., Maqbool, S. 2020. Salivary biomarker interleukin-8 levels in naswar users and non-users. J Coll Physicians Surg Pak, 30(1):99–101.
Ye, D., Gajendra, S., Lawyer, G., Jadeja, N., Pishey, D., Pathagunti, S., Lyons, J., Veazie, P., Watson, G., McIntosh, S., Rahman, I. 2020. Inflammatory biomarkers and growth factors in saliva and gingival crevicular fluid of e-cigarette users, cigarette smokers, and dual smokers: A pilot study. Journal of Periodontology, 91(10):1274–1283. ISSN: 0022-3492, 1943-3670.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.